Modulation of inflammatory response after spinal cord trauma with deferoxamine, an iron chelator

References

• Shapiro S, Borgens R, Pascuzzi R, Roos K, Groff M, Purvines S, Rodgers RB, Hagy S, Nelson P. Oscillating field stimulation for complete spinal cord injury in humans: a phase 1 trial. J Neurosurg Spine 2005;2:3–10.
   PubMed Web of Science ®Google Scholar
• Samadikuchaksaraei A. An overview of tissue engineering approaches for management of spinal cord injuries. J Neuroeng Rehab 2007;4:15.
   PubMed Web of Science ®Google Scholar
• Winkler T, Sharma HS, Gordh T, Badgaiyan RD, Stalberg E, Westman J. Topical application of dynorphin A (1–17) antiserum attenuates trauma induced alterations in spinal cord evoked potentials, microvascular permeability disturbances, edema formation and cell injury: an experimental study in the rat using electrophysiological and morphological approaches. Amino Acids 2002;23:273–281.
   PubMed Web of Science ®Google Scholar
• Conti A, Cardali S, Genovese T, Di Paola R, La Rosa G. Role of inflammation in the secondary injury following experimental spinal cord trauma. J Neurosurg Sci 2003;47:89–94.
   PubMedGoogle Scholar
• Knoblach SM, Huang X, VanGelderen J, Calva-Cerqueira D, Faden AI. Selective caspase activation may contribute to neurological dysfunction after experimental spinal cord trauma. J Neurosci Res 2005;80:369–380.
   PubMed Web of Science ®Google Scholar
• Liu JB, Tang TS, Xiao DS. Changes of free iron contents and its correlation with lipid peroxidation after experimental spinal cord injury. Chin J Traumatol 2004;7:229–232.
   PubMedGoogle Scholar
• Yu J, Guo Y, Sun M, Li B, Zhang Y, Li C. Iron is a potential key mediator of glutamate excitotoxicity in spinal cord motor neurons. Brain Res 2009;1257:102–107.
   PubMed Web of Science ®Google Scholar
• Donfrancesco A, Deb G, Dominici C, Pileggi D, Castello MA, Helson L. Effects of a single course of deferoxamine in neuroblastoma patients. Cancer Res 1990;50:4929–4930.
   PubMed Web of Science ®Google Scholar
• Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood 1997;89:739–761.
   PubMed Web of Science ®Google Scholar
• Gu Y, Hua Y, Keep RF, Morgenstern LB, Xi G. Deferoxamine reduces intracerebral hematoma-induced iron accumulation and neuronal death in piglets. Stroke 2009;40: 2241–2243.
   PubMed Web of Science ®Google Scholar
• Okauchi M, Hua Y, Keep RF, Morgenstern LB, Xi G Effects of deferoxamine on intracerebral hemorrhage-induced brain injury in aged rats. Stroke 2009;40:1858–1863.
   PubMed Web of Science ®Google Scholar
• Sirin BH, Ortac R, Cerrahoglu M, Saribulbul O, Baltalarli A, Celebisoy N, Işkesen I, Rendeci O. Ischaemic preconditioning reduces spinal cord injury in transient ischaemia. Acta Cardiol 2002;57:279–285.
   PubMed Web of Science ®Google Scholar
• Mullane K. Neutrophil-platelet interactions and post-ischemic myocardial injury. Prog Clin Biol Res 1989;301:39–51.
   PubMedGoogle Scholar
• Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351–358.
   PubMed Web of Science ®Google Scholar
• Bethea JR, Castro M, Keane RW, Lee TT, Dietrich WD, Yezierski RP. Traumatic spinal cord injury induces nuclear factor-kappaB activation. J Neurosci 1998;18:3251–3260.
   PubMed Web of Science ®Google Scholar
• Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995;12:1–21.
   PubMed Web of Science ®Google Scholar
• Joshi M, Fehlings MG. Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 2. Quantitative neuroanatomical assessment and analysis of the relationships between axonal tracts, residual tissue, and locomotor recovery. J Neurotrauma 2002;19:191–203.
   PubMed Web of Science ®Google Scholar
• Joshi M, Fehlings MG. Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 1. Clip design, behavioral outcomes, and histopathology. J Neurotrauma 2002;19:175–190.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Keep RF, Hua Y, Schallert T, Hoff JT, Xi G. Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J Neurosurg 2004;100:672–678.
   PubMed Web of Science ®Google Scholar
• Boldt DH. New perspectives on iron: an introduction. Am J Med Sci 1999;318:207–212.
   PubMed Web of Science ®Google Scholar
• Gerlach M, Ben-Shachar D, Riederer P, Youdim MB. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 1994;63:793–807.
   PubMed Web of Science ®Google Scholar
• Fleischer JE, Lanier WL, Milde JH, Michenfelder JD. Failure of deferoxamine, an iron chelator, to improve neurologic outcome following complete cerebral ischemia in dogs. Stroke 1987;18:124–127.
   PubMed Web of Science ®Google Scholar
• Keberle H. The biochemistry of desferrioxamine and its relation to iron metabolism. Ann N Y Acad Sci 1964;119:758–768.
   PubMed Web of Science ®Google Scholar
• Palmer C, Roberts RL, Bero C. Deferoxamine posttreatment reduces ischemic brain injury in neonatal rats. Stroke 1994;25:1039–1045.
   PubMed Web of Science ®Google Scholar
• Porter JB. Deferoxamine pharmacokinetics. Semin Hematol 2001;38:63–68.
   PubMed Web of Science ®Google Scholar
• Jessen KR, Mirsky R. Nonmyelin-forming Schwann cells coexpress surface proteins and intermediate filaments not found in myelin-forming cells: a study of Ran-2, A5E3 antigen and glial fibrillary acidic protein. J Neurocytol 1984;13:923–934.
   PubMedGoogle Scholar
• Ousman SS, David S. MIP-1alpha, MCP-1, GM-CSF, and TNF-alpha control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord. J Neurosci 2001;21:4649–4656.
   PubMed Web of Science ®Google Scholar
• Weiss G, Werner-Felmayer G, Werner ER, Grunewald K, Wachter H, Hentze MW. Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J Exp Med 1994;180:969–976.
   PubMed Web of Science ®Google Scholar
• Gulturk S, Kozan R, Bostanci MO, Sefil F, Bagirici F. Inhibition of neuronal nitric oxide synthase prevents iron-induced cerebellar Purkinje cell loss in the rat. Acta Neurobiol Exp 2008;68:26–31.
   PubMed Web of Science ®Google Scholar
• Olas B, Nowak P, Kolodziejczyk J, Ponczek M, Wachowicz B. Protective effects of resveratrol against oxidative/nitrative modifications of plasma proteins and lipids exposed to peroxynitrite. J Nutr Biochem 2006;17:96–102.
   PubMed Web of Science ®Google Scholar
• Endoh M, Maiese K, Wagner J. Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischemia. Brain Res 1994;651:92–100.
   PubMed Web of Science ®Google Scholar
• Sato K, Tashiro Y, Chibana S, Yamashita A, Karakawa T, Kohrogi H. Role of lipid-derived free radical in bleomycin-induced lung injury in mice: availability for ESR spin trap method with organic phase extraction. Biol Pharm Bull 2008;31:1855–1859.
   PubMed Web of Science ®Google Scholar
• Emerit J, Beaumont C, Trivin F. Iron metabolism, free radicals, and oxidative injury. Biomed Pharmacother 2001;55:333–339.
   PubMed Web of Science ®Google Scholar
• Szabo C, Virag L, Cuzzocrea S, Scott GS, Hake P, O'Connor MP, . Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase. Proc Natl Acad Sci USA 1998;95:3867–3872.
   PubMed Web of Science ®Google Scholar
• Bao X, Wu G, Hu S, Huang F. Poly(ADP-ribose) polymerase activation and brain edema formation by hemoglobin after intracerebral hemorrhage in rats. Acta Neurochir 2008;105: 23–27.
   Google Scholar
• Wu J, Ohlsson M, Warner EA, Loo KK, Hoang TX, Voskuhl RR, Havton LA. Glial reactions and degeneration of myelinated processes in spinal cord gray matter in chronic experimental autoimmune encephalomyelitis. Neuroscience 2008;156: 586–596.
   PubMed Web of Science ®Google Scholar
• Simonart T, Degraef C, Andrei G, Mosselmans R, Hermans P, Van Vooren JP, Noel JC, Boelaert JR, Snoeck R, Heenen M. Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors. J Invest Dermatol 2000;115:893–900.
   PubMed Web of Science ®Google Scholar
• Wilson MR. Apoptotic signal transduction: emerging pathways. Biochem Cell Biol 1998;76:573–582.
   PubMed Web of Science ®Google Scholar
• Nesic-Taylor O, Cittelly D, Ye Z, Xu GY, Unabia G, Lee JC, Svrakic NM, Liu XH, Youle RJ, Wood TG, McAdoo D, Westlund KN, Hulsebosch CE, Perez-Polo JR. Exogenous Bcl-xL fusion protein spares neurons after spinal cord injury. J Neurosci Res 2005;79:628–637.
   PubMed Web of Science ®Google Scholar
• Ackery A, Robins S, Fehlings MG. Inhibition of Fas-mediated apoptosis through administration of soluble Fas receptor improves functional outcome and reduces posttraumatic axonal degeneration after acute spinal cord injury. J Neurotrauma 2006;23:604–616.
   PubMed Web of Science ®Google Scholar
• Barger SW, Van Eldik LJ, Mattson MP. S100 beta protects hippocampal neurons from damage induced by glucose deprivation. Brain Res 1995;677:167–170.
   PubMed Web of Science ®Google Scholar
• Marks A, O'Hanlon D, Lei M, Percy ME, Becker LE. Accumulation of S100 beta mRNA and protein in cerebellum during infancy in Down syndrome and control subjects. Brain Res Mol Brain Res 1996;36:343–348.
   PubMedGoogle Scholar